| Literature DB >> 33087661 |
Wenda Gao1, Mingbo Wang1, Peng Su1, Fan Zhang1, Chao Huang1, Ziqiang Tian1.
Abstract
BACKGROUND: Cervical anastomotic leakage (CAL) is one of the most common complications that occur minimally invasive esophagectomy (MIE). It is associated with high postoperative mortality. Some risk factors still remained controversial and so accurate prediction of risk groups for CAL remained very difficult. This study aimed to identify the risk factors of CAL after McKeown MIE to predict the accuracy of the technique as early as possible.Entities:
Keywords: cervical anastomotic leakage; esophageal cancer; minimally invasive esophagectomy; risk factors
Mesh:
Year: 2020 PMID: 33087661 PMCID: PMC8058540 DOI: 10.5761/atcs.oa.20-00139
Source DB: PubMed Journal: Ann Thorac Cardiovasc Surg ISSN: 1341-1098 Impact factor: 1.520
Characteristics of patients with esophageal cancer according to CAL
| Variable | Total | CAL (n = 31) | NCAL (n = 98) | t/z | p value |
|---|---|---|---|---|---|
| Preoperative | |||||
| Age (years) | 64.05 ± 7.71 | 64.77 ± 6.69 | 63.82 ± 8.02 | 0.602 | 0.549a |
| Gender | 1.251 | 0.263b | |||
| Male | 85 (65.9%) | 23 (74.2%) | 62 (63.3%) | ||
| Female | 44 (34.1%) | 8 (25.9%) | 36 (36.7%) | ||
| BMI (kg/m2) | 23.25 ± 2.94 | 23.70 ± 3.02 | 23.10 ± 2.92 | 0.791 | 0.429c |
| FEV1 (L) | 2.52 ± 0.61 | 2.31 ± 0.55 | 2.58 ± 0.62 | 2.177 | 0.031a |
| FEV1/FVC (%) | 75.75 ± 9.66 | 72.88 ± 10.36 | 76.66 ± 9.29 | 1.695 | 0.090c |
| Diabetes mellitus | 0.069 | 0.792b | |||
| Yes | 11 (8.5%) | 3 (9.7%) | 8 (8.2%) | ||
| No | 118 (91.5%) | 28 (90.3%) | 90 (91.8%) | ||
| Hypertension | 2.157 | 0.142b | |||
| Yes | 52 (40.3%) | 9 (29.0%) | 43 (43.9%) | ||
| No | 77 (59.7%) | 22 (71.0%) | 55 (56.1%) | ||
| Coronary heart disease | 0.424d | ||||
| Yes | 2 (1.6%) | 1 (3.2%) | 1 (1.0%) | ||
| No | 127 (98.4%) | 30 (96.8%) | 97 (99.0%) | ||
| Smoker at diagnosis | 1.390 | 0.238b | |||
| Yes | 63 (48.8%) | 18 (58.1%) | 45 (45.9%) | ||
| No | 66 (51.2%) | 13 (41.9%) | 53 (54.1%) | ||
| Neoadjuvant chemotherapy | 12.045 | 0.001b | |||
| Yes | 29 (22.5%) | 14 (45.2%) | 15 (15.3%) | ||
| No | 100 (77.5%) | 17 (54.8%) | 83 (84.7%) | ||
| Tumor location | 0.273 | 0.873b | |||
| Upper | 17 (13.2%) | 4 (12.9%) | 13 (13.3%) | ||
| Middle | 67 (51.9%) | 15 (48.4%) | 52 (53.1%) | ||
| Lower | 45 (34.9%) | 12 (38.7%) | 33 (33.7%) | ||
| Intraoperative | |||||
| Duration of operation (minutes) | 290.40 ± 46.99 | 298.35 ± 46.69 | 287.89 ± 47.04 | 1.182 | 0.237c |
| Maximum pH in ABG | 7.36 ± 0.06 | 7.34 ± 0.07 | 7.37 ± 0.06 | 1.386 | 0.166c |
| Minimum pH in ABG | 7.23 ± 0.06 | 7.22 ± 0.06 | 7.23 ± 0.06 | 1.127 | 0.260c |
| Mean pH in ABG | 7.29 ± 0.05 | 7.28 ± 0.06 | 7.30 ± 0.05 | 1.546 | 0.125a |
| Maximum PaCO2 in ABG (mmHg) | 60.22 ± 10.93 | 61.52 ± 10.85 | 59.82 ± 10.98 | 1.123 | 0.262c |
| Minimum PaCO2 in ABG (mmHg) | 45.65 ± 6.89 | 44.58 ± 7.34 | 39.41 ± 6.28 | 3.128 | 0.002c |
| Mean PaCO2 in ABG (mmHg) | 49.99 ± 7.17 | 52.10 ± 8.17 | 49.33 ± 6.73 | 1.657 | 0.098c |
| Maximum PaO2 in ABG (mmHg) | 393.64 ± 87.61 | 402.10 ± 86.02 | 390.96 ± 88.73 | 0.626 | 0.532c |
| Minimum PaO2 in ABG (mmHg) | 126.15 ± 74.51 | 120.87 ± 63.25 | 127.82 ± 77.95 | 0.196 | 0.845c |
| Mean PaO2 in ABG (mmHg) | 262.94 ± 78.25 | 266.5 ± 71.7 | 261.8 ± 80.51 | 0.551 | 0.581c |
| Postoperative first day | |||||
| Red blood cell (×1012/L) | 3.88 ± 0.58 | 3.94 ± 0.46 | 3.87 ± 0.61 | 0.565 | 0.573a |
| Hemoglobin (g/L) | 121.58 ± 17.04 | 121.35 ± 15.45 | 121.66 ± 17.59 | 0.807 | 0.931a |
| Blood platelet (109/L) | 200.26 ± 60.26 | 195.26 ± 56.82 | 201.84 ± 61.51 | 0.240 | 0.810c |
| Alanine transaminase (U/L) | 40.87 ± 32.6 | 45.94 ± 51.52 | 39.27 ± 23.98 | 0.466 | 0.641c |
| Albumin (g/L) | 30.32 ± 3.58 | 32.11 ± 3.71 | 32.39 ± 3.91 | 0.355 | 0.723a |
| Postoperative | |||||
| D-dimer (mg/L) | 30.23 ± 2.30 | 3.22 ± 1.96 | 3.24 ± 2.41 | 0.309 | 0.758c |
| Venous thrombosis | 0.015 | 0.902b | |||
| Yes | 24 (18.6%) | 6 (19.4%) | 18 (18.4%) | ||
| No | 105 (81.4%) | 25 (80.6%) | 80 (81.6%) | ||
| Arrhythmia | 1.751 | 0.186b | |||
| Yes | 34 (26.4%) | 11 (35.5%) | 23 (23.5%) | ||
| No | 95 (73.6%) | 20 (64.5%) | 75 (76.5%) | ||
| Histology | 0.006 | 0.940e | |||
| Squamous cell carcinoma | 119 (92.2%) | 28 (90.3%) | 91 (92.9%) | ||
| Others | 10 (7.8%) | 3 (9.7%) | 7 (7.1%) | ||
| TNM stages | 7.299 | 0.063b | |||
| I | 5 (27.1%) | 3 (9.7%) | 32 (32.7%) | ||
| II | 36 (27.9%) | 10 (32.3%) | 26 (26.5%) | ||
| III | 40 (31.0%) | 11 (35.5%) | 29 (29.6%) | ||
| IVA | 18 (14.0%) | 7 (22.6%) | 11 (11.2%) | ||
| Hospital stays (days) | 23.42 ± 14.01 | 35.94 ± 14.59 | 19.42 ± 11.42 | 6.606 | <0.01c |
aIndependent t-test,
bChi-square test,
cMann–Whitney U-test,
dFisher exact test,
eContinuous correction Chi-square test.
ABG: arterial blood gas; BMI: body mass index; CAL: cervical anastomotic leakage
Result of multiple logistic regression analysis in FEV1, neoadjuvant chemotherapy, intraoperative minimum PaCO2 in ABG
| Variable | Adjusted OR | 95% CI | p value |
|---|---|---|---|
| FEV1 | 0.440 | 0.196–0.987 | 0.047 |
| Neoadjuvant chemotherapy | 4.425 | 1.639–11.948 | 0.003 |
| Intraoperative minimum PaCO2 in ABG | 1.14 | 1.052–1.236 | 0.001 |
ABG: arterial blood gas; CI: confidence interval; OR: odds ratio
Sensitivity, specificity, AUC, and cutoff of predictors
| Variable | Sensitivity | Specificity | AUC | Cutoff | p value |
|---|---|---|---|---|---|
| FEV1 | 73.5% | 51.6% | 0.630 | 2.18 | 0.029 |
| Intraoperative Minimum PaCO2 in ABG | 41.9% | 86.7% | 0.686 | 45.5 | 0.002 |
ABG: arterial blood gas; AUC: area under the curve